Logo image of PTP.DE

PENTIXAPHARM HOLDING AG (PTP.DE) Stock Overview

Europe - FRA:PTP - DE000A40AEG0 - Common Stock

1.666 EUR
-0.01 (-0.48%)
Last: 10/27/2025, 7:00:00 PM

PTP.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap41.32M
Revenue(TTM)6.86M
Net Income(TTM)-21220000
Shares24.80M
Float14.05M
52 Week High4.89
52 Week Low1.46
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.69
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2024-10-03
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies


PTP.DE short term performance overview.The bars show the price performance of PTP.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

PTP.DE long term performance overview.The bars show the price performance of PTP.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of PTP.DE is 1.666 EUR. In the past month the price decreased by -9.06%. In the past year, price decreased by -53.79%.

PENTIXAPHARM HOLDING AG / PTP Daily stock chart

PTP.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1EL.MI ESSILORLUXOTTICA 46.1 146.68B
EL.PA ESSILORLUXOTTICA 46.22 147.05B
ESL.DE ESSILORLUXOTTICA 45.25 143.99B
2U3.DE ALCON INC 25.04 32.41B
1ALC.MI ALCON INC 24.71 31.98B
CBHD.DE COLOPLAST-B 31.68 16.98B
AFW.DE ALIGN TECHNOLOGY INC 14.41 8.44B
GENT.OL GENTIAN DIAGNOSTICS ASA 20.82 863.52M
GBT.PA GUERBET 26.33 203.00M
ALCJ.PA CROSSJECT N/A 124.06M
AFME.PA AFFLUENT MEDICAL SA N/A 56.47M
SVS.MI SVAS BIOSANA SPA 7.24 51.52M

About PTP.DE

Company Profile

PTP logo image Pentixapharm Holding AG engages in the development of radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company is headquartered in Berlin, Berlin and currently employs 64 full-time employees. The company went IPO on 2024-10-03. The firm focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. The company is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.

Company Info

PENTIXAPHARM HOLDING AG

Robert-Roessle-Strasse 10

Berlin BERLIN DE

Employees: 64

PTP Company Website

Phone: 493094893220

PENTIXAPHARM HOLDING AG / PTP.DE FAQ

What does PENTIXAPHARM HOLDING AG do?

Pentixapharm Holding AG engages in the development of radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine, and inflammatory diseases. The company is headquartered in Berlin, Berlin and currently employs 64 full-time employees. The company went IPO on 2024-10-03. The firm focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. The company is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.


What is the current price of PTP stock?

The current stock price of PTP.DE is 1.666 EUR. The price decreased by -0.48% in the last trading session.


Does PENTIXAPHARM HOLDING AG pay dividends?

PTP.DE does not pay a dividend.


What is the ChartMill rating of PENTIXAPHARM HOLDING AG stock?

PTP.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the PE ratio for PTP stock?

PENTIXAPHARM HOLDING AG (PTP.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.69).


What is the ownership structure of PENTIXAPHARM HOLDING AG (PTP.DE)?

You can find the ownership structure of PENTIXAPHARM HOLDING AG (PTP.DE) on the Ownership tab.


PTP.DE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PTP.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to PTP.DE. No worries on liquidiy or solvency for PTP.DE as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PTP.DE Financial Highlights

Over the last trailing twelve months PTP.DE reported a non-GAAP Earnings per Share(EPS) of -0.69.


Industry RankSector Rank
PM (TTM) N/A
ROA -41.54%
ROE -51.74%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

PTP.DE Forecast & Estimates

5 analysts have analysed PTP.DE and the average price target is 11.95 EUR. This implies a price increase of 617.55% is expected in the next year compared to the current price of 1.666.


Analysts
Analysts80
Price Target11.95 (617.29%)
EPS Next YN/A
Revenue Next YearN/A

PTP.DE Ownership

Ownership
Inst Owners5.42%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A